XM does not provide services to residents of the United States of America.

D
D

Diageo

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Reuters - 2 weeks ago

AstraZeneca succession sickness demands urgent fix

BREAKINGVIEWS-AstraZeneca succession sickness demands urgent fix The author is a Reuters Breakingviews columnist. The opinions expressed are her own. By Aimee Donnellan LONDON, Sept 15 (Reuters Breakingviews) - Can a CEO be worth $9 billion? That’s the question posed by the 4% fall in AstraZeneca’s AZN.L shares following an article stating boss Pascal Soriot may soon resign.
A
D
G
N
P
S
Reuters - 2 weeks ago

Bureau Veritas, Mediobanca, Vivendi

EUROPE RESEARCH ROUNDUP-Bureau Veritas, Mediobanca, Vivendi Sept 15 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bureau Veritas , Mediobanca and Vivendi on Friday. HIGHLIGHTS * ASML Holding NV ASML.AS : Wolfe Research initiates with outperform rating * Bureau Veritas BVI.PA : Berenberg reinitiates coverage with buy rating * Intesa Sanpaolo SpA ISP.MI : Jefferies raises to buy from hold * Mediobanca MDBI.MI : Jefferies cuts to ho
B
D
D
E
G
I
M
M
M
R
U
V
A
A
A
B
B
B
B
G
I
U
Reuters - 2 weeks ago

Indian winemaker Sula not losing sleep over foreign rivals -CEO

INTERVIEW-Indian winemaker Sula not losing sleep over foreign rivals -CEO By Biplob Kumar Das BENGALURU, Sept 15 (Reuters) - India's largest winemaker, Sula Vineyards SULA.NS , is expanding its production capacity and counting on a pricing sweet spot to fend off foreign rivals in its home turf. Last year, the Indian government slashed import duties for some Australian winemakers as part of a foreign trade agreement (FTA) between the two nations.
D
H
Reuters - 2 weeks ago

BP succession fail puts spotlight on its board

BREAKINGVIEWS-BP succession fail puts spotlight on its board The author is a Reuters Breakingviews columnist. The opinions expressed are his own. By George Hay LONDON, Sept 14 (Reuters Breakingviews) - BP BP.L is keen to move on. Interim CEO Murray Auchincloss on Wednesday stressed that the $110 billion oil giant would stick to its strategy and that Chair Helge Lund and other non-executive directors supported that approach.
B
D
Reuters - 2 weeks ago

Exane sees better value in European beverages than food & HPC

BUZZ-Exane sees better value in European beverages than food & HPC ** Exane BNP Paribas says European beverages sector offers better value than the food and home & personal care (HPC), trading at an around 11% discount to Food & HPC valuations ** It upgrades Italian spirits group Campari CPRI.MI to "neutral" from "underperform", saying the stock is priced for top-line beats that the broker expects to come ** It hikes Campari's target price to 11.8 euros from 10.40 euros, representing a 5% premiu
D
D
P

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.